Managing Side Effects of Newer Therapies for Acute Lymphoblastic Leukemia (ALL)
This activity is the fourth and final module in a series of four educational activities on managing side effects of newer therapies for ALL. Dr. Brandon Hayes-Lattin from Oregon Health & Sciences University, discusses strategies to prevent, monitor, and manage VOD associated with CD22-directed ADC therapy.
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.